All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing the company’s views as of any subsequent date. Forward-looking statements involve substantial risks and uncertainties. This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Marrone Bio Innovations Forward Looking Statements Follow us on social media: Twitter, LinkedIn and Instagram. Learn more about Marrone Bio Innovations at We also use our investor relations website,, as well as our corporate Twitter account, as means of disclosing material non-public information, and encourage our investors and others to monitor and review the information we make public in these locations. Marrone Bio’s research and development program uses proprietary technologies to isolate and screen naturally occurring microorganisms and plant extracts to create new, environmentally sound solutions in agriculture. Our end markets include row crops fruits and vegetables trees, nuts and vines and greenhouse production.

The company’s commercial products are sold globally and supported by a robust portfolio of more than 500 issued and pending patents. Our portfolio of 18 products helps customers operate more sustainably while increasing their return on investment. (NASDAQ: MBII) is a growth-oriented agricultural company leading the movement to environmentally sustainable farming practices through the discovery, development and sale of innovative biological products for crop protection, crop health and crop nutrition. A webcast will also be available for 30 days on the IR section of the Marrone Bio Innovations website or by clicking here: MBII Q1 2022 Webcast. Please use the replay pin number 7668618. To listen, call 1-85 within the United States or 1-40 when calling internationally. Please dial in at least 10 minutes before the start of the call to ensure timely participation.Ī playback of the call will be available through May 18, 2022. To participate, please use the following information:

ET to discuss Marrone Bio Innovations’ first quarter financial results, provide a corporate update, and conclude with a Q&A from participants. Management will host an investor conference call at 4:30 p.m. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the first quarter ended March 31, 2022, after market close on Wednesday, May 11, 2022. RALEIGH, N.C., ApMarrone Bio Innovations, Inc.

Eastern tech all timely